(Q77755243)

English

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

scientific article published on 01 May 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

M Miyazaki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Nagy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Halmos

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K Szepeshazi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Armatis

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

180

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1095-1103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Recombinant Toxins for Cancer Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970600-9

7 January 2021

Identifiers

10.1016/S0002-9378(99)70600-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329861%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77755243&oldid=2149926416"